In Graves' disease (GD), genome‐wide profiling of H3K27ac in CD8+ T cells of patients revealed that the acetylation level of H3K27 decreased in the promoter of inhibitory receptor genes, which may weaken the inhibitory effect of receptor signaling in CD8+ T cells.11 This evidence concerns the gene CD8A and Graves disease.